BCD-261

· Biocad

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for BCD-261, covering 2024-12-16 to 2026-04-17. Get the full timeline:

Most recent: Clinical Trial Update: Evaluate Safety, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of BCD-261 After Single Subcutaneous Injection in Healthy Chinese Volunteers [Phase 1]

See pricing